US Capitol Capsule: Obama closer on trade, but will biopharma get its way?
This article was originally published in Scrip
Executive Summary
With the US Senate voting 62-37 on 22 May, President Barack Obama took a giant leap closer to gaining the fast-track trade promotion authority (TPA) he is seeking to more quickly wrap up the Trans-Pacific Partnership (TPP) negotiations – a pact between the US and 11 other nations, which together make up 40% of the world's gross domestic product.
You may also be interested in...
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Clinton's Drug Price Plan: Threat Or Flash In The Political Pan?
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.